Condition
Allergy to Blomia tropicalis
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Blomia Tropicalis Extract 450 Μgml Solution For Skin Prick Test
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
Phase 3 (1)
Trial Status
Not Yet Recruiting2
Clinical Trials (2)
Showing 2 of 2 trials
NCT07195929Not ApplicableNot Yet Recruiting
Determination of Blomia Tropicalis Allergen Extract in Prick Test Units
SYFe90a1473d1ec4cd3933f459f23df96e5Phase 3Not Yet Recruiting
Blomia tropicalis allergen extract. Study of the sensitivity and specificity of the prick test diagnostic preparation
Showing all 2 trials
Research Network
Common Treatments
- Blomia Tropicalis Extract 450 Μgml Solution For Skin Prick Test1
- Allergenic Extract1
Active Sponsors
- Inmunotek S.L.2
Top Investigators
Hospital Universitario de Canarias
Related Conditions
- Allergic Reactions1
- Allergic Skin Reaction1